The evolution of BaseCase

Posted by Tom Hemy on BaseCase, Value communication

For over a decade, BaseCase has been helping companies to communicate the value of their products during stakeholder engagements. And over this period, our combination of consulting, design, and software expertise, alongside close working relationships with our clients, has kept the BaseCase...

BaseCase 2018 Year in Review

Posted by Tom Hemy on Toolkits, Portal, SQL, Value communication, data manager

Through the launch of brand new add-ons and continuous updates to our existing products, the BaseCase platform evolves each year to ensure it remains the leading value communication platform for the life sciences industry. 2018 was a busy year for us, and we’re happy to share some of our most...

Successfully integrating claims data into effective mobile value communication tools

Posted by Tom Hemy on Claims Data, Value communication

Claims data is a valuable resource for medical device and diagnostics companies as it can be used to demonstrate the impact of new products in the real world. This makes it particularly useful when communicating the value of a product to hospital decision makers, as they increasingly require...

How medical device and diagnostic field teams are utilizing claims data

Posted by Tom Hemy on Claims Data, Value communication

Claims data is available to medical device and diagnostic companies from a variety of sources, such as the CMS in the US. It is a highly valuable resource as it can be used to demonstrate the impact of a product in the real world. This has led to claims data being particularly useful in the...

Expand your global communication strategy with improved support for right-to-left text

The BaseCase platform is uniquely suited to facilitate coordinated rollouts of global market access campaigns. Unlike custom-built, standalone mobile apps, BaseCase apps can be quickly and efficiently adapted to suit different markets using input provided by local affiliates. This allows you to...

How pharma companies are using real-world data in the field

Posted by Tom Hemy on RWD, Real-world data, Value communication

Real-world data (RWD) is available to pharma companies from a variety of sources, for example, the QOF and HES in the UK. It has proven to be a highly valuable resource as it can be used to demonstrate the effectiveness of a drug outside of controlled clinical environments. As a result, this has...

App Export: a new type of tailored leave behind

Posted by Jack Pendleton on BCI, Value communication

Tailored leave behinds are a great way to support and guide the payer decision-making process. Post-engagement, a leave behind summarizing the discussed inputs and calculations not only helps to promote transparency and form a positive lasting impression, but also provides a high-quality...

Successfully integrating RWD into effective value communication tools

Posted by Tom Hemy on Value communication, Real-world data, RWD

Real-world data (RWD) is a valuable resource for pharmaceutical companies as it can be used to demonstrate the impact of new products outside of controlled clinical environments. This makes RWD particularly useful when communicating the effectiveness of a drug to payers. And as today’s payers...

1

Company Updates

Looking for an older blog post?

We recently changed the location of our blog.
Visit the blog archive to find our archived posts.